University of Edinburgh scientists have identified genetic changes that may predict the likelihood of breast cancer relapse in women who take a common type of hormone therapy. It is believed the findings could help to identify those at risk so they can be given alternative treatments which could lower the chances of developing secondary breast cancer.
The researchers studied tumour samples from patients who had been taking aromatase inhibitor for up to two years. None had undergone surgery.
You can read more about the findings on the SBS News website.